| Structure |
Chemical Name |
CAS |
MF |
 |
デュアゾマイシン |
1403-47-0 |
C8H11N3O4 |
 |
バタブリンナトリウム |
195533-98-3 |
C13H6F6NNaO3S |
 |
cis-ジアンミン白金(II)ジクロリド |
15663-27-1 |
Cl2H6N2Pt |
 |
efineptakin alfa |
2026634-47-7 |
|
 |
オキサリプラチン |
61825-94-3 |
C8H12N2O4Pt |
 |
Mirvetuximab |
1453084-36-0 |
|
 |
Interferon |
9008-11-1 |
|
 |
Vadastuximab Talirine |
1436390-64-5 |
|
 |
Enavatuzumab |
1062149-33-0 |
|
 |
Vidutolimod |
147063-80-7 |
|
 |
クロリブリン |
1000852-17-4 |
C18H17BrN4O3 |
 |
3-(4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl)-2-hydroxybenzonitrile hydrochloride |
2361216-83-1 |
C27H23ClF2N4O |
![2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro-](/CAS/20210305/GIF/2230263-60-0.gif) |
2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro- |
2230263-60-0 |
C28H36N6O3 |
![1,8-Naphthyridin-2(1H)-one, 5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-1-benzopyran-6-yl]oxy]-3,4-dihydro-](/CAS/20210305/GIF/2760321-00-2.gif) |
1,8-Naphthyridin-2(1H)-one, 5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-1-benzopyran-6-yl]oxy]-3,4-dihydro- |
2760321-00-2 |
C26H21FN4O3 |
 |
ホスキドン |
114517-02-1 |
C28H22NO6P |
![Immunoglobulin G1, anti-(human B7 homolog 4 protein) (human monoclonal INT-016 γ1-chain), disulfide with human monoclonal INT-016 κ-chain, dimer, reduced, 214′′,214′′′,220,220′,226,226′,229,229′-octakis(thioether) with N-[31-(3-mercapto-2,5-dioxo-3-pyrrolidinyl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[(9S)-9-ethyl-2,3,9,10,13,15-hexahydro-9-hydroxy-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]q](/) |
Immunoglobulin G1, anti-(human B7 homolog 4 protein) (human monoclonal INT-016 γ1-chain), disulfide with human monoclonal INT-016 κ-chain, dimer, reduced, 214′′,214′′′,220,220′,226,226′,229,229′-octakis(thioether) with N-[31-(3-mercapto-2,5-dioxo-3-pyrrolidinyl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[(9S)-9-ethyl-2,3,9,10,13,15-hexahydro-9-hydroxy-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]q |
2760250-80-2 |
|
 |
Talquetamab |
2226212-40-2 |
|
 |
Glembatumumab |
1020264-78-1 |
|
 |
メトプリン |
7761-45-7 |
C11H10Cl2N4 |
 |
2-OHOA |
1229114-68-4 |
C18H35NaO3 |
 |
Anzurstobart |
2543693-10-1 |
|
 |
Yttrium (90Y) Clivatuzumab Tetraxetan |
943976-23-6 |
|
 |
Forimtamig |
2649379-96-2 |
|
 |
catumaxomab |
509077-98-9 |
|
 |
セジラニブ |
288383-20-0 |
C25H27FN4O3 |
 |
カルゼレシン |
119813-10-4 |
C41H37ClN6O5 |
 |
Vorasidenib citrate hemihydrate |
2316810-02-1 |
C14H13ClF6N6.1/2C6H8O7.1/… |
 |
アミノレブリン酸メチル |
33320-16-0 |
C6H12ClNO3 |
 |
Telisotuzumab |
1781223-80-0 |
|
 |
Andecaliximab |
1518996-49-0 |
|
 |
Cetrelimab |
2050478-92-5 |
|
 |
フィルテカンペゴル |
946062-05-1 |
(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC110H106N12O33 |
 |
ファリシマブ(遺伝子組換え) |
1607793-29-2 |
|
 |
Cofetuzumab Pelidotin |
1869937-48-3 |
|
 |
BMS 986158 |
1800340-40-2 |
C30H33N5O2 |
 |
Datopotamab deruxtecan |
2238831-60-0 |
|
![Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car...](/) |
Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car... |
1182215-65-1 |
|
 |
Adegramotide |
1252802-98-4 |
C87H123N19O24 |
 |
ジノスタチン スチマラマー |
123760-07-6 |
|
 |
ペメトレキセドニナトリウム |
150399-23-8 |
C20H22N5NaO6 |
 |
Vanucizumab |
1448221-05-3 |
|
 |
Imvotamab |
2573121-53-4 |
|
 |
Iboctadekin |
479198-61-3 |
|
 |
Iberdomide hydrochloride |
1560678-63-8 |
C25H28ClN3O5 |
 |
Entolimod |
951628-22-1 |
|
 |
Research Grade Vobramitamab (DHJ04006) |
2490556-50-6 |
|
 |
BORTEZOMIB (VELCADE) |
179324-69-7 |
C19H25BN4O4 |
 |
Mitosper |
11056-15-8 |
|
 |
(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide Hydrochloride |
1385020-40-5 |
C20H23ClF2N4O2S |
 |
カルボプラチン |
41575-94-4 |
C6H12N2O4Pt |
 |
Rosomidnar |
871597-03-4 |
|
 |
Zimberelimab |
2259860-24-5 |
|
 |
Muparfostat |
1020105-89-8 |
C12H23O35PS7(C6H10O14S3)n |
 |
エタロシブ |
161172-51-6 |
C33H33FO6 |
 |
Research Grade Oberotatug |
2641919-35-7 |
|
 |
ミトタン |
53-19-0 |
C14H10Cl4 |
 |
ピロキサントロン塩酸塩 |
105118-12-5 |
C21H25N5O4.2ClH |
 |
ネバニミブ塩酸塩 |
133825-81-7 |
C27H40ClN3O |
 |
Yttrium (90Y) Tacatuzumab Tetraxetan |
476413-07-7 |
|
 |
ロサブリン |
501948-05-6 |
C22H16N4O2S |
 |
PSMA-617 |
1702967-37-0 |
C49H71N9O16 |
 |
Verzistobart |
2649466-18-0 |
|
 |
Navicixizumab |
1638338-43-8 |
|
 |
ベムラフェニブ |
918504-65-1 |
C23H18ClF2N3O3S |
 |
Resiquimod Sulfate |
2762439-40-5 |
C17H22N4O2·H2SO4 |
 |
乳酸スクアラミン水和物 |
320725-47-1 |
C37H71N3O8S |
 |
mitomalcin |
11043-99-5 |
|
 |
Zenocutuzumab |
1969309-56-5 |
|
 |
Emirodatamab |
2449199-61-3 |
|
 |
ラブラジミル |
159768-75-9 |
C49H75N15O12S |
 |
Revumenib Citrate |
2761046-45-9 |
C32H47FN6O4S.C6H8O7.H2O |
 |
Calaspargase pegol |
941577-06-6 |
|
 |
オナルツズマブ(遺伝子組換え) |
1133766-06-9 |
|
 |
エナシデニブ |
1446502-11-9 |
C19H17F6N7O |
 |
コンブレタスタチンA4リン酸二ナトリウム |
168555-66-6 |
C18H19O8P.2Na |
 |
ミファムルチド |
838853-48-8 |
C59H112N6NaO20P |
![1-[m-(131I)ヨードベンジル]グアニジン](/CAS/GIF/77679-27-7.gif) |
1-[m-(131I)ヨードベンジル]グアニジン |
77679-27-7 |
|
 |
Ribonuclease (rana pipiens) |
196488-72-9 |
|
 |
リンロドスタット |
1923833-60-6 |
C24H24ClFN2O |
 |
アバスチン |
216974-75-3 |
C6638H10160N1720O2108S44 |
 |
Cibisatamab |
1855925-27-7 |
|
 |
オキシスラン |
27302-90-5 |
C8H9NO2S |
 |
L-Valine, S-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenonyl-2-(aminomethyl)-4-thiazolecarbonyl-2-methylalanyl-, (5→2)-lactone, benzenesulfonate (1:1) |
1834513-67-5 |
C26H39N5O6S2.C6H6O3S |
 |
ONC201 Dihydrochloride |
1638178-82-1 |
C24H27ClN4O |
 |
レナリドミド |
191732-72-6 |
C13H13N3O3 |
 |
citatuzumab |
896731-82-1 |
|
 |
Polzastobart |
2640981-19-5 |
|
![Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester](/CAS/20200331/GIF/1858276-04-6.gif) |
Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester |
1858276-04-6 |
C25H28ClN5O5S2 |
![2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-, hydrochloride (1:1)](/CAS/20211123/GIF/1874231-60-3.gif) |
2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-, hydrochloride (1:1) |
1874231-60-3 |
C26H25ClF3N7O3S |
 |
Mecbotamab |
2460400-28-4 |
|
 |
ベルブリン塩酸塩 |
917369-31-4 |
C17H17N3O.HCl |
 |
Tilsotolimod sodium |
2089768-67-0 |
|
![4-[2-(シクロプロピルメトキシ)-5-メタンスルホニルフェニル]-2-メチルイソキノリン-1-オン](/CAS/20200611/GIF/1706738-98-8.gif) |
4-[2-(シクロプロピルメトキシ)-5-メタンスルホニルフェニル]-2-メチルイソキノリン-1-オン |
1706738-98-8 |
C21H21NO4S |
 |
Sofituzumab Vedotin |
1418200-58-4 |
|
 |
Research Grade Pamvatamig |
2750004-05-6 |
|
 |
Telisotuzumab Vedotin |
1714088-51-3 |
|
 |
シオテロネル |
89672-11-7 |
C16H28O2 |
 |
プラジモチド |
908587-83-7 |
C53H78N10O14 |
 |
Tarlatamab |
2307488-83-9 |
|
 |
シビフェン |
2675-35-6 |
C19H14N4O6 |